Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study
NCT ID: NCT06892418
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-03-30
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Lipidic and Proteic Controlled Diet on Parkinson's Disease
NCT02687698
Motor Learning-based Clinical Pilates Rehabilitation Protocol for Patients with Parkinson's Disease
NCT05899426
Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease
NCT05894473
Balance Confidence and Kinesiophobia in Parkinson's Disease
NCT06751797
The Effect of Cervical Spinal Stabilization Exercises in Patients With Parkinson's Disease
NCT03854747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketoflex 12/3 Diet Group
A plant-based ketogenic diet combined with intermittent fasting (12/3)
Ketoflex 12/3 Diet
A plant-based ketogenic diet combined with intermittent fasting (12/3)
Control Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketoflex 12/3 Diet
A plant-based ketogenic diet combined with intermittent fasting (12/3)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 40-85 years
* Native Turkish speakers
* Able to comply with the study protocol
Exclusion Criteria
* Diagnosis of chronic renal failure
* Presence of neuromuscular disorders
* Having amalgam dental fillings and/or failure to remove them according to the SMART protocol
* Severe vitamin deficiencies that have not been corrected prior to the study
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Lutfu Hanoglu, MD
Professor.MD.PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
İstanbul Medipol Üniversitesi
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD23992
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.